Clinical Trial Update: HUC-MSC for Treatment of High-risk HPV Infection [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating human umbilical cord mesenchymal stem cells (HUC-MSC) for treatment of high-risk human papillomavirus infection; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• HUC-MSC (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Shanghai East Hospital | Conditions: Human Papillomavirus Viruses, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: RECRUITING